𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Facial myokymia in multiple system atrophy

✍ Scribed by Dr. S. B. Blunt; N. M. Khalil; G. D. Perkin


Publisher
John Wiley and Sons
Year
1997
Tongue
English
Weight
400 KB
Volume
12
Category
Article
ISSN
0885-3185

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

Two patients are described with clinical and neuroimaging features consistent with a diagnosis of multiple system atrophy (MSA). The patients are unusual in that facial myokymia became apparent clinically at some stage in their illness. In each patient, the nature and severity of the involuntary facial movements evolved over the course of the illness. Electrophysiologically the movement pattern was consistent with myokymia, and studies of blink‐reflex responses suggested that the myokymic discharges were of brainstem origin. Involuntary facial movements described as facial action myoclonus with electrical characteristics consistent with myoclonus have been described previously in hereditary olivopontocerebellar atrophy (OPCA). Our report describes electrical and clinical features of facial myokymia in MSA with electrical features suggesting hyperexcitability of the facial motorneurons in the brainstem. Such myokymic movements may occur more frequently in MSA than previously recognised but may be missed clinically because of their evolving nature.


πŸ“œ SIMILAR VOLUMES


Survival in multiple system atrophy
✍ Anette Schrag; Gregor K. Wenning; Niall Quinn; Yoav Ben-Shlomo πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 80 KB

## Abstract We here report survival in patients with multiple system atrophy (MSA) in a large, prospectively studied group of patients with MSA. Eighty‐five of 100 patients were known to have died. Three patients were rediagnosed as having PD. Twenty‐four patients came to autopsy, which showed MSA

Therapeutic strategies in multiple syste
✍ Gregor K. Wenning; Felix Geser; Werner Poewe πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 English βš– 92 KB

This review provides an update on therapeutic principles and their implications for practical management in multiple system atrophy (MSA), a sporadic neurodegenerative disorder characterized clinically by various combinations of dysautonomia, Parkinsonism, or cerebellar ataxia, often associated with

Multiple system atrophy: An update
✍ Gregor K. Wenning; Felix Geser; Michaela Stampfer-Kountchev; FranΓ§ois Tison πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 90 KB

Multiple system atrophy (MSA) is a sporadic neurodegenerative disorder that usually manifests in the early sixth decade of life and progresses relentlessly with a mean survival of 9 years. Clinically, MSA is dominated by autonomic/urogenital failure, which may be associated with either levodopa (L-d

Stridor and death in multiple system atr
✍ Michael H. Silber; Samantha Levine πŸ“‚ Article πŸ“… 2000 πŸ› John Wiley and Sons 🌐 English βš– 47 KB πŸ‘ 2 views

Patients with multiple system atrophy (MSA) have a mean survival of 8 to 10 years. Nocturnal stridor has been considered a poor prognostic feature. We analyzed demographic, clinical, and polysomnographic data and obtained follow-up information from 42 patients with MSA (30 with follow-up data) seen